ALLAN TEJADA: Open Payments
NPI 1346752524 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 12 payments from 6 companies in 2025. Trend: 2023 $267 · 2024 $295 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $91 |
| Alkermes, Inc. | 2 | $50 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Lundbeck LLC | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: CAPLYTA, LYBALVI, ABILIFY ASIMTUFII, INGREZZA, FANAPT.
Industry payments across TX — which companies pay providers there.
